Differences Between Progesterone 160mg SR and Micronized Progesterone 200mg
Progesterone 160mg SR (sustained release) and micronized progesterone 200mg differ primarily in their release mechanism, with the SR formulation providing more consistent hormone levels throughout the day compared to standard micronized progesterone.
Key Differences
Release Mechanism
- Progesterone 160mg SR: Provides gradual, sustained release of progesterone over an extended period
- Micronized Progesterone 200mg: Delivers a more immediate release with potential fluctuations in blood levels
Pharmacokinetics
- SR formulation:
- More stable serum levels throughout the day
- Potentially fewer peak-related side effects
- May require less frequent dosing
- Micronized formulation:
- More rapid absorption
- Higher peak concentrations
- May require more frequent dosing to maintain therapeutic levels
Clinical Applications
Both formulations are used in similar clinical scenarios, but with some important considerations:
Hormone Replacement Therapy (HRT):
Preterm Birth Prevention:
- Micronized progesterone 200mg has been studied extensively for preventing preterm birth in women with short cervix 1
- The 200mg formulation is specifically mentioned in guidelines for this indication
Endometrial Protection:
- Both formulations provide endometrial protection, but micronized progesterone 200mg has more extensive clinical evidence 1
Safety Profile
Both formulations share the favorable safety profile of natural progesterone compared to synthetic progestins:
- Lower cardiovascular risk 1
- Neutral or beneficial effect on blood pressure 1
- Better safety profile for thrombotic risk 1, 2
- Fewer metabolic side effects than synthetic progestins 3, 2
Clinical Considerations
When to Consider SR Formulation
- Patients experiencing side effects with standard micronized progesterone
- Those who might benefit from more stable hormone levels
- Patients who prefer once-daily dosing
When to Consider Micronized Progesterone 200mg
- When following evidence-based guidelines that specifically recommend this formulation
- For preterm birth prevention in women with short cervix 1
- For standard HRT regimens with established protocols 1
Common Pitfalls
- Assuming equivalence: The formulations are not directly interchangeable despite similar doses
- Overlooking bioavailability differences: SR formulation may have different overall bioavailability
- Ignoring evidence base: Most clinical guidelines specifically reference the 200mg micronized formulation, particularly for preterm birth prevention and HRT
- Disregarding timing of administration: Micronized progesterone is often recommended at bedtime to minimize side effects like drowsiness 4
Summary
While both formulations contain natural progesterone with similar therapeutic effects, the SR formulation offers more consistent blood levels throughout the day. However, the micronized 200mg formulation has more extensive clinical evidence supporting its use in specific indications like HRT and preterm birth prevention. The choice between formulations should consider the specific indication, patient tolerance, and adherence factors.